DMIIR
Drugs Made In America Acquisition II Corp.
NASDAQ · Financial Services · Asset Management · US
$0.08
+42.86%Price chart
Sep 16Sep 21Sep 24Sep 29Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.05
From 52W high−53.13%
Volume645.00
Market cap$4.92M
P/E (TTM)0.4x
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$0.05
From 52W high
−53.13%
Volume
645.00
Market cap
$4.92M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−3.9x
P/E (TTM)
0.4x
RSI (14)
52.5
MomentumView details →
1D Return
+42.86%
YTD Return
−46.43%
Similar companies
Latest newsMore news →
No recent news for DMIIR.